MedTrace Logo

Combined Aerobic and Resistance Exercise in Peritoneal Dialysis Patients

NCT07634211 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-06-08

No results posted yet for this study

Summary

The goal of this randomized controlled trial was to learn whether a combined aerobic and resistance exercise program could improve physical function and muscle health in people receiving peritoneal dialysis. Researchers compared an exercise group with a control group to evaluate the effects of regular exercise.

The main questions the study aimed to answer were:

* Can regular exercise improve physical performance and muscle strength in people receiving peritoneal dialysis?
* Can regular exercise improve body composition and blood markers related to muscle health?

Before the exercise program, participants completed a one-month training period to learn the exercises and practice them safely.

Participants in the exercise group:

* Performed combined aerobic and resistance exercises for 8 weeks
* Completed assessments before and after the exercise program

Participants in the control group:

* Continued their usual care
* Completed assessments before and after the study period

Conditions

  • Peritoneal Dialysis

Interventions

BEHAVIORAL

Combined Aerobic and Resistance Exercise

Participants performed a structured combined aerobic and resistance exercise program for 8 weeks. Before the intervention period, participants completed a one-month training and adaptation phase to learn the exercises and ensure safe participation. The exercise program aimed to improve physical performance, muscle strength, and muscle health in people receiving peritoneal dialysis.

Sponsors & Collaborators

  • Muğla Sıtkı Koçman University

    collaborator OTHER

  • Dilek GİBYELİ GENEK

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07634211 on ClinicalTrials.gov